Raymond Camahort

Ray joined Novo Ventures in 2015 and has over 15 years of combined research, business development, and venture capital experience. Ray has served as a Board Observer at Checkmate Pharmaceuticals, Arcellx, Stride Bio, and Inspirna. Prior to joining Novo Ventures, Ray worked in business development at the Harvard University Office of Technology Development where he focused on licensing technologies developed in the Departments of Chemistry and Stem Cells and Regenerative Biology.